About OptMed
OptMed is a company based in New York (United States) founded in 2007. OptMed has raised $3.78 million across 8 funding rounds. OptMed offers products and services including BlauProtect and SpectrumEX. OptMed operates in a competitive market with competitors including Neomend, Cohera Medical, Sealonix, GATT Technologies BV and Resivant Medical, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Optmed, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.78 M (USD)
in 8 rounds
-
Latest Funding Round
$200 K (USD), Series A
Jul 29, 2015
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OptMed
OptMed offers a comprehensive portfolio of products and services, including BlauProtect and SpectrumEX.
Protects intact and damaged skin with CE marking for EU use.
Adhesive for closing incisions with FDA clearance for medical applications.
Funding Insights of OptMed
OptMed has successfully raised a total of $3.78M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $200 thousand completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series A — $200,000
-
First Round
First Round
(01 Sep 2009)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2015 | Amount | Series A - OptMed | Valuation |
investors |
|
| Mar, 2015 | Amount | Series A - OptMed | Valuation |
investors |
|
| Jun, 2014 | Amount | Series A - OptMed | Valuation |
investors |
|
Investments & Acquisitions by OptMed
Financial Statements - OptMed
Optmed Comparisons
Competitors of OptMed
OptMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neomend, Cohera Medical, Sealonix, GATT Technologies BV and Resivant Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of air leak sealant for thoracic surgery
|
|
| domain | founded_year | HQ Location |
Develops innovative surgical adhesives and sealants for medical use.
|
|
| domain | founded_year | HQ Location |
Developer of hemostatic sealants for surgeries
|
|
| domain | founded_year | HQ Location |
Polymer-based adhesive tissue tape is developed for surgical sealants.
|
|
| domain | founded_year | HQ Location |
Surgical adhesives for topical skin closure are developed.
|
|
| domain | founded_year | HQ Location |
Wound closure solutions
|
Frequently Asked Questions about OptMed
OptMed was founded in 2007 and raised its 1st funding round 2 years after it was founded.
OptMed is headquartered in New York, United States. It is registered at New York, New York, United States.
OptMed is a funded company, having raised a total of $3.78M across 8 funding rounds to date. The company's 1st funding round was a Series A of $75K, raised on Sep 01, 2009.
OptMed was founded in 2007 in New York, United States, within the biotechnology sector. Biocompatible polymer platforms are developed for biosurgical adhesives, sealants, and industrial applications. Genitourinary therapeutic platforms are focused on treatments for lower urinary tract conditions, such as overactive bladder and kidney stones. Products like Devakor, a topical skin adhesive used in place of surgical sutures, are included in the portfolio. Operations emphasize commercialization of these medical technologies.
OptMed's top competitors include Neomend, GATT Technologies BV and Sealonix.
OptMed offers BlauProtect and SpectrumEX.